Phase I Trial of VC005 Tablets in Renal Impairment Shows Safety and Pharmacokinetics
A Phase I trial is underway to assess the pharmacokinetics and safety of VC005 tablets in subjects with renal impairment.
Asset / Drug
Drug and asset intelligence for VC005 with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.